Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, other cell types. MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cell type for allogenic transplantation. Because of their unique capacity to form structural tissues, MSCs also being explored for use in 3D printing applications. [Read more…]
We Analyzed a Decade of Historical Information on Cord Blood & Cord Tissue Markets (This Is What We Learned)
The cord blood banking market is complex. There are regions experiencing growth and regions experiencing decline. There are extremely successful cord blood banks, and banks that are going out of business or being acquired by the competition.
In addition, there are unique opportunities occurring within the cord blood space that are based on emerging technologies, such as ex vivo expansion of cord blood.
The cord tissue market is also complex, although for different reasons. Today, half of all cord blood banks worldwide offer this service and the number is accelerating. Interestingly, the mesenchymal stem cells (MSCs) contained in cord tissue may have growing opportunities relative to the hematopoietic stem cells (HSCs) contained in cord blood, because MSCs just surpassed HSCs in the scientific literature for the first time in history.
For this reason, BioInformant is offering industry-leading market intelligence for both cord blood and cord tissue markets for the next 14 days only.Â
Act by Feb 29, 2016, and you can get two reports for the price of one, a savings of $3,795.
CORD BLOOD + CORD TISSUE PACKAGE:
- Complete 2015-16 Global Cord Blood Banking Industry Report
- Mesenchymal Stem Cells – Advances & Applications
This is an exclusive offer available only to BioInformant readers, so enter the coupon code “CordBloodCordTissue” during checkout (for either product) and you will automatically receive the other report for free.Â
To compete within the global cord blood banking market, you need to be informed about both cord blood and cord tissue markets. This is your opportunity to get a strategic edge.
Do You Know Opportunities for Commercializing Stem Cells, by Stem Cell Type?
Commonly investigated stem cell types include embryonic stem cells (ESCs), as well as adult stem cell types that include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs). There are also other less common stem cell types, including dental pulp stem cells (DPSCs), adipose-derived stem cells (ADSCs), and a variety of perinatal stem cell types, including amniotic stem cells, placental stem cells, umbilical cord blood stem cells, and cord tissue stem cells.
Cancer stem cells also exist, giving rise to clonal populations of cells that form tumors or disperse within the body. Each of these stem cell types represents unique opportunities for research product development.
Importantly, literature concerning the biology, characteristics, and applications of stem cells has flourished over the past few decades.
In full-year 2015, there were 25,613 stem cell scientific publications released, and an all-time search returns 259,218 stem cell scientific publications (Pubmed.gov). [Read more…]
Is It the Era for Mesenchymal Stem Cells (MSCs)?
Wow! For the first time in history, the research of mesenchymal stem cells surpassed hematopoietic stem cell research within the scientific literature in 2015.
This is major news for the stem cell community, because it represents a shift in stem cell research activity.
Mesenchymal stem cells, of the five types analyzed, were the only type to also experience an increase in frequency of publication from 2014 to 2015 as well. Conversely, all four other types experienced decreases in publication during the aforementioned period.
Check out the metrics here:Â Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature for the 1st Time in History [Read more…]
Why I Respectfully Disagree with Other Market Intelligence Reports about Cord Blood Banking
Recently, I’ve seen posts on LinkedIn and the web for a cord blood market report titled “Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 – 2020.”
I rarely reflect on products by other companies, but this report is disturbing in that it is painfully inaccurate.
As global business expert Joe Polish likes to say, “The most expensive information is bad information,” and this is a case of that situation.
In the Executive Summary, a highlight of the main findings for this report, Allied Market Research states that the “Cord blood market is expected to grow at 33.5% CAGR from 2012-2020.”
[Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 8
- Next Page »